100
Participants
Start Date
July 31, 2007
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
0.04% Mechlorethamine gel
Mechlorethamine 0.04% PG applied to affected skin areas (lesions) once daily for up to seven (7) months. The frequency of application may be adjusted for toxicity. After seven (7) months, they will be terminated from the study.
Columbia University, Dept of Dermatology, New York
NYU Medical Center Dept. of Dermatology, New York
Duke University Medical Center, Durham
University of Wisconsin, Madison
Northwestern University-Dept. of Dermatology, Chicago
Oklahoma University, Tulsa
University of Texas, Southwestern Medical Center, Dallas
The University of Texas, M.D. Anderson Cancer Center, Houston
Utah Clinical Trials, LLC, Salt Lake City
Stanford University Medical Center, Stanford
Fox Chase Cancer Center, Philadelphia
Lead Sponsor
Yaupon Therapeutics
INDUSTRY